News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News TransNusa Launches Maiden Bali-Phuket Flight for the Ultimate Island-Hopping Experience News The 43rd Hong Kong Watch & Clock Design Competition results announced News Universitas Brawijaya Forest operates thermal drone to strengthen fire mitigation News YDC 2026 unveils its winners in spectacular fashion News TMX Group Consolidated Trading Statistics – August 2026 News Pioneer AI Foundry Board Composition Changes
